Correlation Between Anika Therapeutics and Schwab 5

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and Schwab 5 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and Schwab 5 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anika Therapeutics and Schwab 5 10 Year, you can compare the effects of market volatilities on Anika Therapeutics and Schwab 5 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of Schwab 5. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and Schwab 5.

Diversification Opportunities for Anika Therapeutics and Schwab 5

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Anika and Schwab is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and Schwab 5 10 Year in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Schwab 5 10 and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with Schwab 5. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Schwab 5 10 has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and Schwab 5 go up and down completely randomly.

Pair Corralation between Anika Therapeutics and Schwab 5

Given the investment horizon of 90 days Anika Therapeutics is expected to under-perform the Schwab 5. In addition to that, Anika Therapeutics is 17.42 times more volatile than Schwab 5 10 Year. It trades about -0.17 of its total potential returns per unit of risk. Schwab 5 10 Year is currently generating about 0.06 per unit of volatility. If you would invest  2,241  in Schwab 5 10 Year on August 30, 2024 and sell it today you would earn a total of  11.00  from holding Schwab 5 10 Year or generate 0.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

Anika Therapeutics  vs.  Schwab 5 10 Year

 Performance 
       Timeline  
Anika Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Schwab 5 10 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Schwab 5 10 Year are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong technical indicators, Schwab 5 is not utilizing all of its potentials. The new stock price confusion, may contribute to short-horizon losses for the traders.

Anika Therapeutics and Schwab 5 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anika Therapeutics and Schwab 5

The main advantage of trading using opposite Anika Therapeutics and Schwab 5 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, Schwab 5 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Schwab 5 will offset losses from the drop in Schwab 5's long position.
The idea behind Anika Therapeutics and Schwab 5 10 Year pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Directory
Find actively traded commodities issued by global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.